胃食管反流病药物选择中的临床和经济因素 - Suppr

Suppr

超能文献

Clinical and economic factors in the selection of drugs for gastroesophageal reflux disease.

作者信息

Bate C M, Richardson P D

机构信息

Royal Albert Edward Infirmary, Lancashire, England.

出版信息

Pharmacoeconomics. 1993 Feb;3(2):94-9. doi: 10.2165/00019053-199303020-00002.

DOI:10.2165/00019053-199303020-00002

PMID:10146958

Abstract

摘要

相似文献

Clinical and economic factors in the selection of drugs for gastroesophageal reflux disease.

Pharmacoeconomics. 1993 Feb;3(2):94-9. doi: 10.2165/00019053-199303020-00002.

Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease.

Pharmacoeconomics. 1999 Nov;16(5 Pt 1):483-97. doi: 10.2165/00019053-199916050-00006.

Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease.

Arch Intern Med. 1992 Jul;152(7):1467-72.

Economic analysis of alternative treatments for persistent gastro-oesophageal reflux disease.

Scand J Gastroenterol Suppl. 1994;201:98-102. doi: 10.3109/00365529409105374.

A cost-utility analysis comparing omeprazole with ranitidine in the maintenance therapy of peptic esophageal stricture.

Can J Gastroenterol. 1998 Jan-Feb;12(1):43-9. doi: 10.1155/1998/947087.

[Bronchial asthma and gastroesophageal reflux disease: are they interrelated by chance?].

Klin Med (Mosk). 2005;83(1):9-14.

Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.

Ital J Gastroenterol Hepatol. 1998 Feb;30(1):19-27.

Empiric therapy for gastroesophageal reflux disease.

Arch Intern Med. 1995 Sep 11;155(16):1808-12.

Dig Dis. 1998 Sep-Oct;16(5):284-91. doi: 10.1159/000016878.

Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.

Clin Pharmacokinet. 1996 Nov;31(5):386-406. doi: 10.2165/00003088-199631050-00005.

引用本文的文献

Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL.

Qual Life Res. 2004 Dec;13(10):1751-62. doi: 10.1007/s11136-004-8751-3.

Ranitidine: a pharmacoeconomic evaluation of its use in acid-related disorders.

Pharmacoeconomics. 1994 Jul;6(1):57-89. doi: 10.2165/00019053-199406010-00007.

Dig Dis Sci. 1996 Nov;41(11):2123-9. doi: 10.1007/BF02071390.

Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group.

Gut. 1995 Apr;36(4):492-8. doi: 10.1136/gut.36.4.492.

Functional dyspepsia. Current treatment recommendations.

Drugs. 1993 Jun;45(6):918-930. doi: 10.2165/00003495-199345060-00005.

本文引用的文献

Esophageal disorders in the etiology and pathophysiology of dyspepsia.

Scand J Gastroenterol Suppl. 1985;109:133-43. doi: 10.3109/00365528509103947.

Open-access upper alimentary endoscopy.

Br J Hosp Med. 1989 May;41(5):438, 440, 442-4.

Diagnosis of gastroesophageal reflux disease.

Scand J Gastroenterol Suppl. 1989;156:21-4. doi: 10.3109/00365528909091034.

Epidemiology of oesophageal reflux disease.

Scand J Gastroenterol Suppl. 1989;168:33-7.

Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations.

Gut. 1990 Sep;31(9):968-72. doi: 10.1136/gut.31.9.968.

Omeprazole. Overview and opinion.

Dig Dis Sci. 1991 Apr;36(4):385-93. doi: 10.1007/BF01298864.

Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease.

Arch Intern Med. 1992 Jul;152(7):1467-72.

Open access endoscopy--a nationwide survey of current practice.

Gut. 1992 Feb;33(2):282-5. doi: 10.1136/gut.33.2.282.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验